Parker Geoffrey M. — SEC insider filings

SEC reporting owner CIK 1491874. 53 insider filings on record with FilingPulse; latest filed 2026-10-23.

Transaction summary — filings shown

Covers the 50 most recent of 53 filings on record, filed 2021-03-08 to 2026-10-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ChemoCentryx, Inc. (CCXI)Director6—3 legs · 31,910 sh · $1,806,44820
PERRIGO Co plc (PRGO)Director228 legs · 42,250 sh · $1,210,589—35
Better Therapeutics, Inc. (BTTX)Director95 legs · 1,048,055 sh · $917,212—5
Allogene Therapeutics, Inc. (ALLO)CHIEF FINANCIAL OFFICER101 leg · 190 sh · $6834 legs · 101,448 sh · $144,65311
Tricida, Inc. (TCDA)COO, CFO and EVP3——4

Insider filings — Parker Geoffrey M.

FiledFormIssuerReported transactionsSource
2026-10-234Allogene Therapeutics, Inc. (ALLO)Sale (S): 36,342 @ $1.34EDGAR
2026-09-154PERRIGO Co plc (PRGO)Option exercise (M): 1,263 @ $13.66 · Tax withholding (F): 607 @ $13.66 · Option exercise (M): 1,263 (derivative)EDGAR
2026-06-164PERRIGO Co plc (PRGO)Option exercise (M): 976 @ $10.99 · Tax withholding (F): 469 @ $10.99 · Grant/award (A): 844 (derivative) · Option exercise (M): 976 (derivative)EDGAR
2026-05-154PERRIGO Co plc (PRGO)Option exercise (M): 7,305 @ $10.84 · Tax withholding (F): 3,507 @ $10.84 · Grant/award (A): 16,681 (derivative) · Option exercise (M): 7,305 (derivative)EDGAR
2026-03-174PERRIGO Co plc (PRGO)Grant/award (A): 3,024 (derivative)EDGAR
2026-02-044Allogene Therapeutics, Inc. (ALLO)Sale (S): 24,001 @ $1.76 · Grant/award (A): 539,072 (derivative) @ $0 · Grant/award (A): 152,480 (derivative) @ $0EDGAR
2025-12-164PERRIGO Co plc (PRGO)Grant/award (A): 2,140 (derivative)EDGAR
2025-11-144PERRIGO Co plc (PRGO)Purchase (P): 7,500 @ $14.18EDGAR
2025-10-234Allogene Therapeutics, Inc. (ALLO)Sale (S): 36,744 @ $1.26EDGAR
2025-09-164PERRIGO Co plc (PRGO)Grant/award (A): 1,263 (derivative)EDGAR
2025-08-204/APERRIGO Co plc (PRGO)Purchase (P): 4,375 @ $22.97EDGAR
2025-08-194PERRIGO Co plc (PRGO)Purchase (P): 4,375 @ $22.97EDGAR
2025-06-174PERRIGO Co plc (PRGO)Grant/award (A): 976 (derivative)EDGAR
2025-05-164PERRIGO Co plc (PRGO)Option exercise (M): 9,904 @ $26.01 · Tax withholding (F): 4,754 @ $26.01 · Grant/award (A): 7,305 (derivative) · Option exercise (M): 9,904 (derivative)EDGAR
2025-05-144PERRIGO Co plc (PRGO)Purchase (P): 3,500 @ $27.10EDGAR
2025-02-054Allogene Therapeutics, Inc. (ALLO)Sale (S): 4,361 @ $1.73EDGAR
2025-01-284Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 173,913 @ $0 · Grant/award (A): 614,844 (derivative) @ $0EDGAR
2024-10-234Allogene Therapeutics, Inc. (ALLO)Tax withholding (F): 36,404 @ $2.84EDGAR
2024-05-204Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 344,828 @ $2.90EDGAR
2024-05-164PERRIGO Co plc (PRGO)Option exercise (M): 8,764 @ $30.22 · Tax withholding (F): 4,207 @ $30.22 · Grant/award (A): 9,904 (derivative) · Option exercise (M): 8,764 (derivative)EDGAR
2024-03-064Allogene Therapeutics, Inc. (ALLO)Purchase (P): 190 @ $3.60EDGAR
2024-01-314Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 29,400 @ $0 · Grant/award (A): 103,939 (derivative) @ $0EDGAR
2023-12-204Better Therapeutics, Inc. (BTTX)Grant/award (A): 3,750 @ $0EDGAR
2023-10-174Allogene Therapeutics, Inc. (ALLO)Grant/award (A): 400,000 @ $0 · Grant/award (A): 390,000 @ $0 · Grant/award (A): 950,000 (derivative) @ $0EDGAR
2023-07-314Better Therapeutics, Inc. (BTTX)Purchase (P): 685,025 @ $0.73EDGAR
2023-06-144PERRIGO Co plc (PRGO)Purchase (P): 10,000 @ $33.06EDGAR
2023-06-094Better Therapeutics, Inc. (BTTX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-05-194PERRIGO Co plc (PRGO)Option exercise (M): 7,778 @ $32.86 · Tax withholding (F): 3,734 @ $32.86 · Option exercise (M): 7,778 (derivative)EDGAR
2023-05-174PERRIGO Co plc (PRGO)Grant/award (A): 8,764 (derivative)EDGAR
2023-04-124Better Therapeutics, Inc. (BTTX)Purchase (P): 303,030 @ $0.82EDGAR
2023-03-074PERRIGO Co plc (PRGO)Purchase (P): 5,000 @ $38.05EDGAR
2022-10-244ChemoCentryx, Inc. (CCXI)Disposition to issuer (D): 107,997 · Disposition to issuer (D): 21,076 · Disposition to issuer (D): 5,000 · Disposition to issuer (D): 8,342 (derivative) · Disposition to issuer (D): 4,504 (derivative) · Disposition to issuer (D): 12,287 (derivative) · +3 moreEDGAR
2022-06-144Better Therapeutics, Inc. (BTTX)Purchase (P): 25,000 @ $1.45EDGAR
2022-06-104Better Therapeutics, Inc. (BTTX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-05-314ChemoCentryx, Inc. (CCXI)Grant/award (A): 15,723 (derivative) · Grant/award (A): 8,342 (derivative)EDGAR
2022-05-244ChemoCentryx, Inc. (CCXI)Option exercise (M): 7,726 @ $0 · Option exercise (M): 7,726 (derivative)EDGAR
2022-05-194PERRIGO Co plc (PRGO)Option exercise (M): 6,599 @ $38.57 · Tax withholding (F): 3,168 @ $38.57 · Grant/award (A): 7,778 (derivative) · Option exercise (M): 6,599 (derivative)EDGAR
2022-05-034ChemoCentryx, Inc. (CCXI)Option exercise (M): 12,500 @ $14.42 · Option exercise (M): 12,500 (derivative)EDGAR
2022-03-314Better Therapeutics, Inc. (BTTX)Purchase (P): 15,000 @ $2.15EDGAR
2022-03-024Tricida, Inc. (TCDA)Grant/award (A): 256,000 (derivative) @ $0EDGAR
2022-01-044Tricida, Inc. (TCDA)Tax withholding (F): 1,384 @ $9.56EDGAR
2021-12-174PERRIGO Co plc (PRGO)Purchase (P): 5,000 @ $36.85EDGAR
2021-12-164Better Therapeutics, Inc. (BTTX)Purchase (P): 20,000 @ $4.94EDGAR
2021-11-174Tricida, Inc. (TCDA)Grant/award (A): 166,667 @ $6 · Grant/award (A): 166,667 (derivative)EDGAR
2021-11-014Better Therapeutics, Inc. (BTTX)Grant/award (A): 33,333 · Grant/award (A): 28,300 (derivative) @ $0EDGAR
2021-05-244ChemoCentryx, Inc. (CCXI)Gift (G): 4,000 @ $0 · Option exercise (M): 4,660 @ $0 · Grant/award (A): 7,726 (derivative) · Grant/award (A): 4,504 (derivative) · Option exercise (M): 4,660 (derivative)EDGAR
2021-05-194PERRIGO Co plc (PRGO)Grant/award (A): 6,599 (derivative)EDGAR
2021-05-114PERRIGO Co plc (PRGO)Option exercise (M): 5,804 @ $42.96 · Tax withholding (F): 2,786 @ $42.96 · Option exercise (M): 5,804 (derivative)EDGAR
2021-03-184PERRIGO Co plc (PRGO)Purchase (P): 2,500 @ $41.29EDGAR
2021-03-084ChemoCentryx, Inc. (CCXI)Sale (S): 1,910 @ $60.20 · Sale (S): 16,670 @ $56.78 · Sale (S): 13,330 @ $55.89EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1491874 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs